Pfizer Can't Shake Investor Suit Over Off-Label Marketing

Law360, New York (August 10, 2011, 3:21 PM EDT) -- A New York federal judge refused Wednesday to dismiss a putative securities class action stemming from a $2.3 billion civil and criminal fine Pfizer Inc. paid for illegally marketing off-label uses of four drugs and offering doctors kickbacks to promote the medications.

The company had argued that the “plaintiffs’ prolix and confusing complaint — their third — [failed] to remedy the shortcomings identified” in an April order instructing them to refer only to certain exhibits necessary for the understanding of the allegations.

Pfizer pointed out that...
To view the full article, register now.




Case Information

Case Title

Jones et al v. Pfizer, Inc. et al

Case Number



New York Southern

Nature of Suit



Alvin K. Hellerstein

Date Filed

May 11, 2010

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.